We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novel Fights 'Patient' Claim Rehearing In Suprep Suit

Law360, New York (July 7, 2014, 7:22 PM EDT) -- Generic drug producer Novel Laboratories Inc. urged the Federal Circuit on Thursday to deny Braintree Laboratories Inc.’s bid for an en banc rehearing on the construction of the term “a patient”...
To view the full article, register now.




Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

June 10, 2013

Law Firms

Government Agencies


Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.